Clinical trial

Multiple Dose Study in Heart Failure of BAY 1067197

NCT02040233

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-01-28

PhasePHASE2

Study timeline

Study start (actual)2014-01-28Date precision: day

Registry last updated2019-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

BAY1067197 (10 mg)DRUG

BAY1067197DRUG

Placebo (10 mg)DRUG

PlaceboDRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

BerlinGermany1 WroclawPoland1 GroningenNetherlands1 MilanLombardy, Italy1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02040233 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.